Lung cancer is the leading cause of cancer death in America,
yet gets less research funding than other major cancer groups.

You can make a difference!

Who Should Care About Lung Cancer

Anyone with lungs can develop lung cancer. Click to open larger. It is a disease that claims more lives than breast, prostate, colon and kidney cancers COMBINED, making it the leading cause of cancer deaths. Over 158,000 lives are lost to this devastating disease each year. Despite this, lung cancer research ...
Read More

FDA Grants Breakthrough Therapy Designation For Genentech’s Alecensa ®

Genentech, a member of the Roche Group, announced on October 3, 2016 that it has received a second Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase (ALK) inhibitor, Alecensa (alectinib)... FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT ...
Read More

Our MISSION and GOAL

Our mission is to increase public awareness and understanding about lung cancer and to promote screening and early detection in order to save lives.

Research, awareness and advocacy have been the catalyst for improvements in the screening, diagnosis and treatments of other cancers. We need to do the same for lung cancer. Research investment saves lives!

The Lung Cancer Research Council seeks to engage lung cancer survivors, family members, friends, neighbors and co-workers in SW Florida. The opportunity to partner together will help in advancing lung cancer awareness, accelerating research and improving outcomes for lung cancer patients. We are excited for you to join us! Your commitment to work with us will improve the lives of many people in our community.


Feeling Fit Articles

FDA Grants Breakthrough Therapy Designation For Genentech’s Alecensa ®

Genentech, a member of the Roche Group, announced on October 3, 2016 that it has received a second Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase (ALK) inhibitor, Alecensa (alectinib)... FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC – This Second Alecensa Breakthrough Therapy Designation Was Granted Based on Phase III J-ALEX Study  – SOUTH SAN FRANCISCO, Calif. – October ...
Read More

Ten Essential Facts about Lung Cancer

Did you know that lung cancer is the leading cause of cancer deaths in the U.S. but is the least funded? Read more essential facts about lung cancer in this presentation and learn what you can to help in raising funds and awareness with the Lung Cancer Research Council.   ...
Read More

Immunotherapy and its Ability to Fight Cancer

Unlike chemotherapy that attacks cancer directly, immunotherapy leverages a patient’s own immune system to help battle disease. Learn more about how immunotherapy helped a lung cancer patient restore his health and more in this New York Times article by Denise Grady. (more...) ...
Read More

Hot Topics

FDA Grants Breakthrough Therapy Designation For Genentech’s Alecensa ®

Genentech, a member of the Roche Group, announced on October 3, 2016 that it has received a second Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase ...
Read More

Ten Essential Facts about Lung Cancer

Did you know that lung cancer is the leading cause of cancer deaths in the U.S. but is the least funded? Read more essential facts about lung cancer in this presentation and learn what you ...
Read More

Genentech’s cancer immunotherapy TECENTRIQTM (atezolizumab) helped people with a specific type of lung cancer live significantly longer compared to chemotherapy

The latest news on Genentech's immunotherapy molecule Tecentriq (atezolizumab) for NSCLC: Genetech’s Phase III Study, OAK, helped people with a specific type of lung cancer live significantly longer compared to chemotherapy, demonstrating significant improvement in ...
Read More

Lung Cancer Research Council hosts 4th annual SW Florida 5K Run/Walk Nov. 5

The Lung Cancer Research Council will host its fourth annual SW Florida 5K Run/Walk and Mile of Memories Memorial Walk on Nov. 5 at the Charlotte Sports Park, located at 2300 El Jobean Rd. in ...
Read More